Jim Simons’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$447M Sell
1,004,888
-166,683
2025
Q1
$568M Sell
1,171,571
-225,638
2024
Q4
$563M Sell
1,397,209
-234,284
2024
Q3
$759M Buy
1,631,493
+65,105
2024
Q2
$734M Sell
1,566,388
-14,100
2024
Q1
$661M Sell
1,580,488
-11,200
2023
Q4
$648M Sell
1,591,688
-72,400
2023
Q3
$579M Buy
1,664,088
+391,927
2023
Q2
$448M Sell
1,272,161
-125,574
2023
Q1
$440M Sell
1,397,735
-849,017
2022
Q4
$649M Buy
2,246,752
+107,867
2022
Q3
$619M Buy
2,138,885
+377,717
2022
Q2
$496M Buy
1,761,168
+53,800
2022
Q1
$446M Buy
1,707,368
+80,500
2021
Q4
$357M Sell
1,626,868
-264,618
2021
Q3
$343M Sell
1,891,486
-385,798
2021
Q2
$459M Sell
2,277,284
-123,000
2021
Q1
$516M Sell
2,400,284
-1,175,646
2020
Q4
$845M Sell
3,575,930
-1,631,002
2020
Q3
$1.42B Sell
5,206,932
-574,400
2020
Q2
$1.68B Sell
5,781,332
-1,078,350
2020
Q1
$1.63B Sell
6,859,682
-216,900
2019
Q4
$1.55B Buy
7,076,582
+1,277,465
2019
Q3
$982M Buy
5,799,117
+243,300
2019
Q2
$1.02B Buy
5,555,817
+477,100
2019
Q1
$934M Buy
5,078,717
+744,417
2018
Q4
$718M Buy
4,334,300
+245,183
2018
Q3
$788M Buy
4,089,117
+38,500
2018
Q2
$688M Buy
4,050,617
+1,199,700
2018
Q1
$465M Buy
2,850,917
+3,000
2017
Q4
$427M Buy
2,847,917
+1,479,897
2017
Q3
$208M Buy
1,368,020
+1,346,320
2017
Q2
$2.8M Sell
21,700
-18,417
2017
Q1
$4.39M Buy
+40,117
2016
Q3
Sell
-60,517
2016
Q2
$5.21M Sell
60,517
-52,100
2016
Q1
$8.95M Buy
112,617
+51,300
2015
Q4
$7.72M Buy
+61,317
2015
Q2
Sell
-159,317
2015
Q1
$18.8M Buy
+159,317
2014
Q2
Sell
-312,164
2014
Q1
$22.1M Buy
+312,164
2013
Q4
Sell
-139,220
2013
Q3
$10.6M Buy
+139,220